CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory Methodology

References

• Ploemacher, R. E., van der Sluijs, J. P., Voerman, J. S. A. and Brons, N. H. C. (1989). An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood, 74, 2755–63.
   PubMed Web of Science ®Google Scholar
• Ploemacher, R. E., van der Sluijs, J. P., van Beurden, C. A. J., Baert, M. R. M. and Chan, P. L. (1991). Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood, 78, 2527–33.
   PubMed Web of Science ®Google Scholar
• Van der Sluijs, J. P., de Jong, J.P., Brons, N. H. C. and Ploemacher, R. E. (1990). Marrow repopulating cells, but not CFU-S, establish long-term in vitro hemopoiesis on a marrow-derived stromal layer. Exp. Hematol., 18, 893–6.
   PubMed Web of Science ®Google Scholar
• Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C. and Eaves, C. J. (1990). Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Nat. Acad. Sci. USA, 87, 3584–8.
   PubMed Web of Science ®Google Scholar
• Dexter, T. M., Allen, T. D. and Lajtha, L. G. (1977). Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol., 91, 335–44.
   PubMed Web of Science ®Google Scholar
• Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F. and Shaper, J. H. (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol., 133, 157–65.
   PubMed Web of Science ®Google Scholar
• Andrews, R. G., Singer, J. W. and Bernstein, I. D. (1986). Monoclonal antibody 12–8 recognizes a 115 kd molecule present on both unipotent and multipotent colony-forming cells and their precursors. Blood, 67, 842–5.
   PubMed Web of Science ®Google Scholar
• Tindle, R. W., Nichols, R. A. B., Chan, L., Campano, D., Catovsky, D. and Birnie, G. D. (1985). A novel monoclonal antibody BI-3C5 recognizes myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk. Res., 1, 1–9.
   Google Scholar
• Katz, F., Tindle, R. W., Sutherland, D. R. and Greaves, M. F. (1985). Identification of a membrane glycoprotein associated with haematopoietic progenitor cells. Leuk. Res., 9, 191–8.
   PubMed Web of Science ®Google Scholar
• Watt, S. M., Karhi, K., Gatter, K. et al. (1987). Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic cells. Leukemia, 1, 417–26.
   PubMed Web of Science ®Google Scholar
• Hogg, N. and Horton, M. A. (1987). Myeloid antigens: new and previously defined clusters. In Leucocyte Typing III, edited by A. McMichael, pp. 576–602 Oxford: Oxford University Press.
   Google Scholar
• Briddell, R. A., Brandt, J. E., Straneva, J. E. et al. (1989). Characterization of the human burst-forming unitmegakaryocyte. Blood, 74, 145–51.
   PubMed Web of Science ®Google Scholar
• Lu, L., Walker, D., Broxmeyer, H. E. et al. (1987). Characterization of adult bone marrow hematopoietic progenitors highly enriched by two-colour sorting with MY-10 and major histocompatibility class II monoclonal antibodies. J. Immunol., 139, 1823–9.
   PubMed Web of Science ®Google Scholar
• Katz, F. E., Watt, S. M., Martin, H. et al. (1986). Coordinate expression of BI-3C5 and HLA-DR antigens on haemopoietic progenitors from chronic myeloid leukaemia. Leuk. Res., 10, 961–71.
   PubMed Web of Science ®Google Scholar
• Ryan, D., Kossover, S., Mitchell, S. et al. (1986). Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood, 68, 417–25.
   PubMed Web of Science ®Google Scholar
• Loken, M. R., Shah, V. O., Dattillio, K. L. et al. (1987). Flow cytometric analysis of human bone marrow: II. Normal B lymphocyte development. Blood, 70, 1316–24.
   PubMed Web of Science ®Google Scholar
• Holyoake, T. L., Alcorn, M. J. and Franklin, I. M. (1996). The CD34 antigen: potential clinical advantages of CD34 selection. Clinical Oncology, 8, 214–21.
   Google Scholar
• Gazitt, Y., Reading, C. C., Hoffman, R. et al. (1995). Purified CD34 positive Lin-Thy positive stem cells do not contain clonal myeloma cells. Blood, 86, 381–9.
   PubMed Web of Science ®Google Scholar
• Vescio, R. A., Hong, C. H., Cao, J. et al. (1994). The hematopoietic stem cell antigen CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283–90.
   PubMed Web of Science ®Google Scholar
• Berenson, R. J., Andrews, W. I., Bensinger, D. et al. (1988). Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J. Clin. Invest., 81, 951–5.
   PubMed Web of Science ®Google Scholar
• Brugger, W., Henschler, R., Heimfeld, S. et al. (1994). Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment following high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood, 84, 1421–6.
   PubMed Web of Science ®Google Scholar
• Schiller, G., Vescio, R., Freytes, C. et al. (1995). Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390–7.
   PubMed Web of Science ®Google Scholar
• Negrin, R. S., Kusnierz-Glaz, C. R., Still, B. J. et al. (1995). Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood, 85, 3334–41.
   PubMed Web of Science ®Google Scholar
• Gorin, N. C., Lopez, M., Laporte, J. P. et al. (1995). Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood, 85, 1647–54.
   PubMed Web of Science ®Google Scholar
• Shpall, E. J., Jones, R. B., Bearman, S. I. et al. (1994). Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J. Clin. Oncol., 12, 28–36.
   PubMed Web of Science ®Google Scholar
• Holyoake, T. L., Alcorn, M. J., Richmond, L. J. et al. (1994). Efficient isolation of CD34+ hemopoietic progenitor cells by immune panning. Stem Cells, 12,114–24.
   PubMed Web of Science ®Google Scholar
• Berenson, R. J., Bensinger, W. I., Hill, R. S. et al. (1991). Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood, 1717–22.
   Google Scholar
• Fruehauf, S., Haas, R., Zeller, W. J. et al. (1994). CD34 selection for purging in multiple myeloma and analysis of CD34+B cell precursors. Stem Cells, 12, 95–102.
   PubMed Web of Science ®Google Scholar
• Miltenyi, S., Muller, W., Weichel, W. et al. (1990). High gradient magnetic separation with MACS. Cytometry, 11, 231–8.
   PubMedGoogle Scholar
• Kessinger, A. and Armitage, J. O. (1991). The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood, 77, 211–3.
   PubMed Web of Science ®Google Scholar
• Dreger, P., Viehmann, K., Steinmann, J. et al. (1995). GCSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Exp. Hematol., 23, 147–54.
   PubMed Web of Science ®Google Scholar
• Vogel, W., Behringer, D., Scheding, S., Kanz, L. and Brugger, W. (1996). Ex vivo expansion of CD34+peripheral blood progenitor cells: Implications for the expansion of contaminating epithelial tumor cells. Blood, 88, 2707–2713.
   PubMed Web of Science ®Google Scholar
• Williams, S. F., Lee, W. J., Bender, J. G. et al. (1996). Selection and expansion of peripheral blood CD34+cells in autologous stem cell transplantation for breast cancer. Blood, 87, 1687–91.
   PubMed Web of Science ®Google Scholar
• Alcorn, M. J., Holyoake, T. L., Richmond, L. et al. (1996). CD34-positive cells isolated from cryopreserved peripheral blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J. Clin. Oncol., 14, 1839–47.
   PubMed Web of Science ®Google Scholar
• Brugger, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R. and Kanz, L. (1995). Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Eng. J. Med., 333, 283–7.
   PubMed Web of Science ®Google Scholar
• Nolta, J. A., Smogorzewska, E. M. and Kohn, D. B. (1995). Analysis of optimal conditions for retroviralmediated transduction of primitive human hematopoietic cells. Blood, 86, 101–10.
   PubMed Web of Science ®Google Scholar
• Muench, M. O. and Moore, M. A. S. (1992). Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp. Hematol., 20, 611–8.
   PubMed Web of Science ®Google Scholar
• Muench, M. O., Firpo, M. T. and Moore, M. A. S. (1993). Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferation potential. Blood, 81, 3463–73.
   PubMed Web of Science ®Google Scholar
• Serrano, F., Varas, F., Bernad, A. and Bueren, J. A. (1994). Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplant, 14, 855–62.
   PubMed Web of Science ®Google Scholar
• Holyoake, T. L., Freshney, M. G., McNair, L. et al. (1996). Ex vivo expansion with SCF and IL-11 augments both short term recovery post-transplant and the ability to serially transplant marrow. Blood, 87, 4589–95.
   PubMed Web of Science ®Google Scholar
• Rebel, V. I., Dragowska, W., Eaves, C. J., Humphries, R. K. and Lansdorp, P. M. (1994). Amplication of Sca-1+ Lin-WGA+ cells in serum-free cultures containing Steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood, 83, 128–36.
   PubMed Web of Science ®Google Scholar
• Brandt, J., Briddell, R. A., Srour, E. F, Leemhuis, T. B. and Hoffman, R. (1992). Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood, 79, 634–41.
   PubMed Web of Science ®Google Scholar
• Haylock, D. N., To, L. B., Dowse, T. L., Juttner, C. A. and Simmons, P. J. (1992). Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood, 80, 1405–12.
   PubMed Web of Science ®Google Scholar
• Leary, A. G., Ikebuchi, K., Hirai, Y. et al. (1988). Synergism between intereleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-lα. Blood, 71, 1759–63.
   PubMed Web of Science ®Google Scholar
• Brugger, W., Möcklin, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R. and Kanz, L. (1993). Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1β (IL-lβ), IL-6, IL-3, interferon-γ and erythropoietin. Blood, 81, 2579–84.
   PubMed Web of Science ®Google Scholar
• Shapiro, F., Yao, T.-J., Raptis, G., Reich, L., Norton, L. and Moore, M. A. S. (1994). Optimization of conditions for ex vivo expansion of CD34+cells from patients with stage IV breast cancer. Blood, 84, 3567–74.
   PubMed Web of Science ®Google Scholar
• Srour, E. F, Brandt, J. E., Briddell, R. A., Grigsby, S., Leemhuis, T. and Hoffman, R. (1993). Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood, 81, 661–9.
   PubMed Web of Science ®Google Scholar
• Varfaillie, C. M. (1993). Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood, 82, 2045–53.
   PubMed Web of Science ®Google Scholar
• Lyman, S. D., James, L., Bos, T. V., et al. (1993). Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell, 75, 1157–67.
   PubMed Web of Science ®Google Scholar
• Hannum, C., Culpepper, J., Campbell, D. et al. (1994). Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature, 368, 643–8.
   PubMed Web of Science ®Google Scholar
• Petzer, A. L., Hogge, D. E., Lansdorp, P. M., Reid, D. S. and Eaves, C. J. (1996). Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc. Nat. Acad. Sci., USA, 93, 1470–4.
   PubMed Web of Science ®Google Scholar
• Szilvassy, S. J., Humphries, R. K., Lansdorp, P. M., Eaves, A. C. and Eaves, C. J. (1990). Quantitative assay for totipotent reconstituting hemopoietic stem cells by a competitive repopulation strategy. Proc. Nat. Acad. Sci., USA, 87, 8736–40.
   PubMed Web of Science ®Google Scholar
• Goan, S.-R., Schwarz, K., von Harsdof, S., von Schilling, C., Fichtner, I., Junghahn, I., Just, U. and Herrmann, F. (1996). Fibroblasts retrovirally transfected with the human IL-3 gene initiate and sustain multilineage human hematopoiesis in SCID mice: comparison of CD34-enriched vs CD34-enriched and in vitro expanded grafts. Bone Marrow Transplant., 18, 513–9.
   PubMed Web of Science ®Google Scholar
• Dick, J. E. (1991). Immune-deficient mice as models of normal and leukemic hematopoiesis. Cancer Cells, 3, 39–48.
   PubMed Web of Science ®Google Scholar
• Lapidot, T., Pflumio, F., Doedens, M., Murdoch, B., Williams, D. E. and Dick, J. E. (1992). Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science, 255, 1137–41.
   PubMed Web of Science ®Google Scholar
• Vormoor, J., Lapidot, T., Pflumio, F., Risdon, G., Patterson, B., Broxmeyer, H. E. and Dick, J. E. (1994). Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immuno-deficient mice. Blood, 83, 2489–97.
   PubMed Web of Science ®Google Scholar
• Schwartz, R., Emerson, S. G., Clarke, M. F. and Palsson, B. O. (1991). In vitro myelopoiesis stimulated by rapid medium exchange and supplementation with hematopoietic growth factors. Blood, 78, 3155–61.
   PubMed Web of Science ®Google Scholar
• Koller, M. R., Emerson, S. G. and Palsson, B. O. (1993). Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion culture. Blood, 82, 378–84.
   PubMed Web of Science ®Google Scholar
• Koller, M. R., Palsson, M. A., Manchel, I. and Palsson, B. (1995). Long-term culture initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood, 86, 1784–93.
   PubMed Web of Science ®Google Scholar
• Zandstra, P. W., Eaves, C. J., Cameron, G. and Piret, J. M. (1995). Cytokine depletion in long-term stirred suspension cultures of normal human marrow. J. Hematother., 4, 235a.
   Google Scholar
• Verfaillie, C. M., Catanzarro, P. M. and Li, W.-N. (1994). Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J. Exp. Med., 179, 643–9.
   PubMed Web of Science ®Google Scholar
• Gupta, P., McCarthy, J. B. and Verfaillie, C. M. (1996). Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood, 87, 3229–36.
   PubMed Web of Science ®Google Scholar
• Bhatia, R., McGlave, P. B., Lin, W., Wissink, S., Miller, J. S. and Verfaillie, C. M. (1995). Ex vivo expansion of LTCIC and CFC present in CD34+ HLA-DR- cells is possible in a clinically suitable stroma conditioned medium culture supplemented with one or two cytokines. Blood, 86, (suppl. 1), 294a.
   PubMedGoogle Scholar
• Holyoake, T. L., Freshney, M. G., Konwalinka, G. et al. (1993). Mixed colony formation in vitro by the heterogeneous compartment of multipotential progenitors in human bone marrow. Leukemia, 7, 207–13.
   PubMed Web of Science ®Google Scholar
• Holyoake, T. L. and Alcorn, M. J. (1994). CD34 positive haemopoietic cells: biology and clinical applications. Blood Reviews, 8, 113–24.
   PubMed Web of Science ®Google Scholar
• Mason, D. Y. and Erber, W. N. (1991). Immunocytochemical labeling of leukemia samples with monoclonal antibodies by the APAAP procedure. In The Leukemic Cell, edited by D. Catovsky, pp. 196–214. Edinburgh: Churchill Livingstone.
   Google Scholar
• Silver, S. M., Adams, P. T., Hutchinson, R. J. et al. (1993). Phase I evaluation of ex vivo expanded hematopoietic cells produced by perfusion cultures in autologous bone marrow transplantation. Blood, 82, (Suppl 1), 295a.
   Google Scholar
• Champlin, R., Mehra, R., Gajewski, L. et al. (1995) Ex vivo expanded progenitor cell transplantation in patients with breast cancer. Blood, 86, (Suppl 1), 295a.
   Google Scholar
• Holyoake, T. L., Alcorn, M. J. and Richmond, L. et al. (1995). A phase I study to evaluate the saftey of reinfusing CD34 cells expanded ex vivo as part or all of a PBPC transplant procedure. Blood, 86, (Suppl 1), 294a.
   PubMedGoogle Scholar
• Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L. and Leiter, E. H. (1995). Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol., 154, 180–191.
   PubMed Web of Science ®Google Scholar